Literature DB >> 1975593

Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden.

M A Salih1, D Danielsson, A Bäckman, D A Caugant, M Achtman, P Olcén.   

Abstract

A random selection of 25 strains isolated during an epidemic caused by serogroup A Neisseria meningitidis in Sudan (1988), 3 preepidemic meningococcal strains (1985), and 26 serogroup A strains isolated from sporadic cases of meningitis in Sweden (1973 to 1987) were assessed for multilocus enzyme genotypes (ETs), DNA restriction enzyme patterns, outer membrane proteins, lipopolysaccharides, pilus formation, and antibiograms. All of the 25 Sudanese epidemic isolates and 22 of the Swedish strains were of the same or closely related ETs (ETs 3, 4, and 5), corresponding to clone III-1, which has been responsible for two pandemic waves in the last three decades. The earlier pandemic involved Scandinavia, and the last one caused an outbreak during the pilgrimage to Mecca, Saudi Arabia (August 1987), spreading to Sudan, Chad, and Ethiopia. The three Sudanese preepidemic isolates (1985) were clone IV-1 (sulfonamide susceptible), which has been resident in the African meningitis belt for the last 25 years. The uniformity of clone III-1 strains (all sulfonamide resistant) from Sudan and Sweden was confirmed by DNA restriction enzyme patterns. ETs 3, 4, and 5 from Sudan and Sweden had 86 to 100% similarity to a Swedish clone III-1 reference strain, whereas ETs 1, 2, 6, and 7 showed 50 to 80% similarity. Class 1 protein for clone III-1 showed serosubtype antigens P1.9 and P1.x, whereas ET6 strains (clone IV-1) had serosubtype P1.7. Lipopolysaccharides were variable in the Sudanese and Swedish strains. Pili were expressed in all clone III-1 isolates from Sudan and Sweden but in none of the clone IV-1 isolates (Sudan, 1985).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975593      PMCID: PMC268034          DOI: 10.1128/jcm.28.8.1711-1719.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

Review 1.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

2.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

Review 4.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

5.  In-vitro and in-vivo studies of resistance to rifampin in meningococci.

Authors:  T C Eickhoff
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

6.  Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers.

Authors:  D A Caugant; K Bøvre; P Gaustad; K Bryn; E Holten; E A Høiby; L O Frøholm
Journal:  J Gen Microbiol       Date:  1986-03

7.  Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern.

Authors:  D A Caugant; L F Mocca; C E Frasch; L O Frøholm; W D Zollinger; R K Selander
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

8.  Trial of chloramphenicol for meningitis in northern savanna of Africa.

Authors:  H C Whittle; N M Davidson; B M Greenwood; D A Warrell; A Tomkins; P Tugwell; A Zalin; A D Bryceson; E H Parry; M Brueton; M Duggan; A D Rajković
Journal:  Br Med J       Date:  1973-08-18

9.  Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.

Authors:  B Schwartz; A Al-Tobaiqi; A Al-Ruwais; R E Fontaine; J A'ashi; A W Hightower; C V Broome; S I Music
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

10.  Control of epidemic group A meningococcal meningitis in Nepal.

Authors:  S L Cochi; L E Markowitz; D D Joshi; R C Owens; D H Stenhouse; D N Regmi; R P Shrestha; I Lacharya; M Manandhar; V L Gurubacharya
Journal:  Int J Epidemiol       Date:  1987-03       Impact factor: 7.196

View more
  22 in total

1.  The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitidis strains.

Authors:  P Nicolas; G Raphenon; M Guibourdenche; L Decousset; R Stor; A B Gaye
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

3.  COVID-19 and lessons learned from the pandemic wave of meningococcal meningitis (1985-1990).

Authors:  Mohammed Osman Swar
Journal:  Sudan J Paediatr       Date:  2020

4.  Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern.

Authors:  J Y Riou; D A Caugant; R K Selander; J T Poolman; M Guibourdenche; E Collatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-05       Impact factor: 3.267

5.  Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Authors:  Pierre Nicolas; Gunnstein Norheim; Eric Garnotel; Saacou Djibo; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil.

Authors:  C T Sacchi; R C Zanella; D A Caugant; C E Frasch; N T Hidalgo; L G Milagres; L L Pessoa; S R Ramos; M C Camargo; C E Melles
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

7.  Building Gaafar Ibnauf Children's Hospital: Unprecedented story.

Authors:  Mohammed Osman Swar
Journal:  Sudan J Paediatr       Date:  2015

8.  Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.

Authors:  X X Gu; C M Tsai; A B Karpas
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

Review 9.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

10.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.